The Long View A WEEKLY FROM ALLOCRA FY 2026/27 6 APR JUL OCT JAN 5 APR
Now Publishing

A Friday read for self-directed investors.

The Long View is a weekly evidence-led brief from Allocra. Short sections, no fluff, no fund-hyping, no email gate. Built for self-directed investors in the UK and US who would rather read the maths than the marketing.

New issue every Friday morning at 07:00 UK

What you will get each Friday

Short sections drawn from the editorial menu below, designed to be read in five minutes over a cup of coffee. Each issue features a selection from the five sections rather than all of them; The Story and The Closer appear every week, and the rest earn their place when the week gives them something worth saying. Every issue anchors to one of the 10 Decisions from the Allocra guide, then looks at one thing happening in the market that week through the same evidence-led lens.

Section
The Chart
One chart, one principle, anchored to the 10 Decisions framework.
Section
The Story
One macro, regulatory, or industry development that matters this week.
Section
Hype Watch
One thing being over-discussed, with the counter-evidence.
Section
The Diary
What is on the calendar next week that you should actually care about.
Section
The Closer
One sharp closing thought. That is the whole section.

What you will not get

No stock picks. No hot takes. No promoted funds. No affiliate links. No subscriber-only paywall. The Long View is an editorial product, not a sales channel. If a fund manager pays us nothing, we owe them nothing, and that is by design.

How to read it

Every issue publishes openly on this page at 07:00 UK on Friday. Open to read, no email gate, no signup required to access an issue. If you want it in your inbox so you never miss an edition, drop your email on the Allocra homepage. Content earns the subscription, not the other way around.

Spotted something getting hyped?

The Hype Watch section runs on reader tips. If you have seen a product, fund, or trend being talked up that deserves the same maths-versus-marketing treatment, send it through. We will consider it for a future issue. hype@allocra.co

The Long View is editorial commentary from Allocra Ltd, a UK-registered company. Allocra Ltd is not authorised or regulated by the Financial Conduct Authority. Nothing on this page or in any issue constitutes investment, tax, or financial advice. Always do your own research or speak to a qualified adviser before acting on anything you read here.